Journal of Nuclear Medicine: 62 (9)

September 1, 2021; Volume 62,Issue 9

Editor’s Page

You have access
The Annual Journal Impact Factor Saga
Johannes Czernin

Journal of Nuclear Medicine September 1, 2021, 62 (9) 1177; DOI: https://doi.org/10.2967/jnumed.120.262860

Discussions with Leaders

You have access
Leadership Focus on Advancing Cancer Research and Treatment
Johannes Czernin, Caius Radu and Antoni Ribas

Journal of Nuclear Medicine September 1, 2021, 62 (9) 1178-1180; DOI: https://doi.org/10.2967/jnumed.121.262937

State of the Art

You have access
Image-Guided High-Intensity Focused Ultrasound, A Novel Application for Interventional Nuclear Medicine?
Xinrui Zhang, Lisa Landgraf, Nikolaos Bailis, Michael Unger, Thies H. Jochimsen and Andreas Melzer

Journal of Nuclear Medicine September 1, 2021, 62 (9) 1181-1188; DOI: https://doi.org/10.2967/jnumed.120.256230

Hot Topics

You have access
Why Will PET Be the Future of Nuclear Cardiology?
Marcelo F. Di Carli

Journal of Nuclear Medicine September 1, 2021, 62 (9) 1189-1191; DOI: https://doi.org/10.2967/jnumed.120.254979

Continuing Education

You have access
Systemic Radiopharmaceutical Therapy of Pheochromocytoma and Paraganglioma
Jorge A. Carrasquillo, Clara C. Chen, Abhishek Jha, Karel Pacak, Daniel A. Pryma and Frank I. Lin

Journal of Nuclear Medicine September 1, 2021, 62 (9) 1192-1199; DOI: https://doi.org/10.2967/jnumed.120.259697

Focus on Molecular Imaging

You have access
Current Landscape in Clinical Pretargeted Radioimmunoimaging and Therapy
Vilma I.J. Jallinoja and Jacob L. Houghton

Journal of Nuclear Medicine September 1, 2021, 62 (9) 1200-1206; DOI: https://doi.org/10.2967/jnumed.120.260687

Issues and Controversies

You have access
Diversity, Equity, and Inclusion in Academic Nuclear Medicine: National Survey of Nuclear Medicine Residency Program Directors
Jocelyn L. Cheng, Elizabeth H. Dibble, Grayson L. Baird, Leonie L. Gordon and Hyewon Hyun

Journal of Nuclear Medicine September 1, 2021, 62 (9) 1207-1213; DOI: https://doi.org/10.2967/jnumed.120.260711

Oncology

Clinical
- You have access
  Value of ¹⁸F-FES PET in Solving Clinical Dilemmas in Breast Cancer Patients: A Retrospective Study
  Jorianne Boers, Naila Loudini, Celina L. Brunsch, Sylvia A. Koza, Erik F.J. de Vries, Andor W.J.M. Glaudemans, Geke A.P. Hospers and Carolina P. Schröder
  
  Journal of Nuclear Medicine September 1, 2021, 62 (9) 1214-1220; DOI: https://doi.org/10.2967/jnumed.120.256826
- FEATURED CLINICAL INVESTIGATION ARTICLE
  - You have access
    Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
    Caroline Bodet-Milin, Alain Faivre-Chauvet, Thomas Carlier, Catherine Ansquer, Aurore Rauscher, Eric Frampas, Frederique Toulgoat, Damien Masson, Mickael Bourgeois, Evelyne Cerato, Vincent Rohmer, Olivier Couturier, Delphine Drui, David M. Goldenberg, Robert M. Sharkey, Jacques Barbet and Francoise Kraeber-Bodere
    
    Journal of Nuclear Medicine September 1, 2021, 62 (9) 1221-1227; DOI: https://doi.org/10.2967/jnumed.120.252791

Basic

FEATURED ARTICLE OF THE MONTH
- You have access
  Synthesis and Preclinical Evaluation of a ⁶⁸Ga-Labeled Adnectin, ⁶⁸Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
  Stephanie Robu, Antonia Richter, Dario Gosmann, Christof Seidl, David Leung, Wendy Hayes, Daniel Cohen, Paul Morin, David J. Donnelly, Daša Lipovšek, Samuel J. Bonacorsi, Adam Smith, Katja Steiger, Christina Aulehner, Angela M. Krackhardt and Wolfgang A. Weber
  
  Journal of Nuclear Medicine September 1, 2021, 62 (9) 1228-1234; DOI: https://doi.org/10.2967/jnumed.120.258384

Theranostics

Clinical
- You have access
  ⁶⁸Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma
  Nader Hirmas, Catherine Leyh, Miriam Sraieb, Francesco Barbato, Benedikt M. Schaarschmidt, Lale Umutlu, Michael Nader, Heiner Wedemeyer, Justin Ferdinandus, Christoph Rischpler, Ken Herrmann, Pedro Fragoso Costa, Christian M. Lange, Manuel Weber and Wolfgang P. Fendler
  
  Journal of Nuclear Medicine September 1, 2021, 62 (9) 1235-1241; DOI: https://doi.org/10.2967/jnumed.120.257915
- EDITORIAL
  - You have access
    PSMA Theranostics: Is the Time Ripe to Pave the Way to Further Tumor Entities?
    Winfried Brenner, Joachim Strobel and Vikas Prasad
    
    Journal of Nuclear Medicine September 1, 2021, 62 (9) 1242-1243; DOI: https://doi.org/10.2967/jnumed.121.262737
- You have access
  The Impact of Monosodium Glutamate on ⁶⁸Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
  Wesley R. Armstrong, Andrei Gafita, Shaojun Zhu, Pan Thin, Kathleen Nguyen, Rejah Alano, Stephanie Lira, Kiara Booker, Linda Gardner, Tristan Grogan, David Elashoff, Martin Allen-Auerbach, Magnus Dahlbom, Johannes Czernin and Jeremie Calais
  
  Journal of Nuclear Medicine September 1, 2021, 62 (9) 1244-1251; DOI: https://doi.org/10.2967/jnumed.120.257931
- You have access
  Combination of Forced Diuresis with Additional Late Imaging in ⁶⁸Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer Uptake
  Ian Alberts, Jan Niklas-Hünermund, Christos Sachpekidis, Helle Damgaard Zacho, Clemens Mingels, Lotte Dijkstra, Karl Peter Bohn, Tilman Läppchen, Eleni Gourni, Axel Rominger and Ali Afshar-Oromieh
  
  Journal of Nuclear Medicine September 1, 2021, 62 (9) 1252-1257; DOI: https://doi.org/10.2967/jnumed.120.257741
- Open Access
  Head-to-Head Comparison of ⁶⁸Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10–Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients
  Melline G.M. Schilham, Patrik Zamecnik, Bastiaan M. Privé, Bas Israël, Mark Rijpkema, Tom Scheenen, Jelle O. Barentsz, James Nagarajah and Martin Gotthardt
  
  Journal of Nuclear Medicine September 1, 2021, 62 (9) 1258-1263; DOI: https://doi.org/10.2967/jnumed.120.258541
- You have access
  SUVs Are Adequate Measures of Lesional ¹⁸F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
  Yves J.L. Bodar, Berend P.F. Koene, Bernard H.E. Jansen, Matthijs C.F. Cysouw, Dennie Meijer, N. Harry Hendrikse, André N. Vis, Ronald Boellaard and Daniela E. Oprea-Lager
  
  Journal of Nuclear Medicine September 1, 2021, 62 (9) 1264-1269; DOI: https://doi.org/10.2967/jnumed.120.260232
- BRIEF COMMUNICATION
  - You have access
    Detection of Early Progression with ¹⁸F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy
    Mark C. Markowski, Pedro Isaacsson Velho, Mario A. Eisenberger, Martin G. Pomper, Kenneth J. Pienta, Michael A. Gorin, Emmanuel S. Antonarakis, Samuel R. Denmeade and Steven P. Rowe
    
    Journal of Nuclear Medicine September 1, 2021, 62 (9) 1270-1273; DOI: https://doi.org/10.2967/jnumed.120.259226
- BRIEF COMMUNICATION
  - Open Access
    Addition of ¹³¹I-MIBG to PRRT (⁹⁰Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
    David L. Bushnell, Kellie L. Bodeker, Thomas M. O’Dorisio, Mark T. Madsen, Yusuf Menda, Stephen Graves, Gideon K.D. Zamba and M. Sue O’Dorisio
    
    Journal of Nuclear Medicine September 1, 2021, 62 (9) 1274-1277; DOI: https://doi.org/10.2967/jnumed.120.254987
- You have access
  Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
  David L. Chan, Gary A. Ulaner, David Pattison, David Wyld, Rahul Ladwa, Julian Kirchner, Bob T. Li, W. Victoria Lai, Nick Pavlakis, Paul J. Roach and Dale L. Bailey
  
  Journal of Nuclear Medicine September 1, 2021, 62 (9) 1278-1284; DOI: https://doi.org/10.2967/jnumed.120.257659

ENDOCRINOLOGY

You have access
Assessment and Comparison of ¹⁸F-Fluorocholine PET and ^99mTc-Sestamibi Scans in Identifying Parathyroid Adenomas: A Metaanalysis
Julia Whitman, Isabel E. Allen, Emily K. Bergsland, Insoo Suh and Thomas A. Hope

Journal of Nuclear Medicine September 1, 2021, 62 (9) 1285-1291; DOI: https://doi.org/10.2967/jnumed.120.257303

NEUROLOGY

Clinical
- You have access
  Tau^IQ: A Canonical Image Based Algorithm to Quantify Tau PET Scans
  Alex Whittington, Roger N. Gunn and for the Alzheimer’s Disease Neuroimaging Initiative
  
  Journal of Nuclear Medicine September 1, 2021, 62 (9) 1292-1300; DOI: https://doi.org/10.2967/jnumed.120.258962
- SPECIAL CONTRIBUTION
  - You have access
    Hypermetabolism on Pediatric PET Scans of Brain Glucose Metabolism: What Does It Signify?
    Harry T. Chugani
    
    Journal of Nuclear Medicine September 1, 2021, 62 (9) 1301-1306; DOI: https://doi.org/10.2967/jnumed.120.256081
Basic
- You have access
  Dopamine D₁ Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
  Olivier Barret, Lei Zhang, David Alagille, Cristian C. Constantinescu, Christine Sandiego, Caroline Papin, Jenna M. Sullivan, Thomas Morley, Vincent M. Carroll, John Seibyl, Jianqing Chen, Chewah Lee, Anabella Villalobos, David Gray, Timothy J. McCarthy and Gilles Tamagnan
  
  Journal of Nuclear Medicine September 1, 2021, 62 (9) 1307-1313; DOI: https://doi.org/10.2967/jnumed.120.256008

MOLECULAR IMAGING

Basic
- BRIEF COMMUNICATION
  - You have access
    Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery
    Samaneh Azargoshasb, Krijn H.M. Houwing, Paul R. Roos, Sven I. van Leeuwen, Michael Boonekamp, Elio Mazzone, Kevin Bauwens, Paolo Dell’Oglio, Fijs W.B. van Leeuwen and Matthias N. van Oosterom
    
    Journal of Nuclear Medicine September 1, 2021, 62 (9) 1314-1317; DOI: https://doi.org/10.2967/jnumed.120.259796

Challenging Case Studies

You have access
Distinguishing Primary Lateral Sclerosis from Parkinsonian Syndromes with the Help of Advanced Imaging
Pegah Masrori, Donatienne Van Weehaeghe, Koen Van Laere and Philip Van Damme

Journal of Nuclear Medicine September 1, 2021, 62 (9) 1318-1319; DOI: https://doi.org/10.2967/jnumed.121.261942

Letters to the Editor

You have access
Bowel Obstruction as a Complication of Peptide Receptor Radionuclide Therapy
Christopher E. Wee, Ayca Dundar, Rachel A. Eiring, Mohamed Badawy, Timothy J. Hobday, A. Tuba Kendi, Annie T. Packard and Thorvardur R. Halfdanarson

Journal of Nuclear Medicine September 1, 2021, 62 (9) 1320; DOI: https://doi.org/10.2967/jnumed.121.262048
You have access
Reply: Bowel Obstruction as a Complication of Peptide Receptor Radionuclide Therapy
Jonathan R. Strosberg, Taymeyah Al-Toubah and Ghassan El-Haddad

Journal of Nuclear Medicine September 1, 2021, 62 (9) 1321; DOI: https://doi.org/10.2967/jnumed.121.262340

SNMMI Newsline

You have access
This Month in JNM
Journal of Nuclear Medicine September 1, 2021, 62 (9) 8A;
You have access
JNM 2020 Impact Factor Rises Sharply
Journal of Nuclear Medicine September 1, 2021, 62 (9) 9N;
You have access
FDA Encourages Inclusion of Incurable Cancers in Trials
Journal of Nuclear Medicine September 1, 2021, 62 (9) 9N;
You have access
ABNM Celebrating 50 Years
George M. Segall

Journal of Nuclear Medicine September 1, 2021, 62 (9) 10N;
You have access
Progress in Prostate Cancer Theranostics
Richard L. Wahl

Journal of Nuclear Medicine September 1, 2021, 62 (9) 11N;
You have access
Newsbriefs
Journal of Nuclear Medicine September 1, 2021, 62 (9) 12N-14N;

Main menu

User menu

Search

Table of Contents

Editor’s Page

Discussions with Leaders

State of the Art

Hot Topics

Continuing Education

Focus on Molecular Imaging

Issues and Controversies

Oncology

Clinical

FEATURED CLINICAL INVESTIGATION ARTICLE

Basic

FEATURED ARTICLE OF THE MONTH

Theranostics

Clinical

EDITORIAL

BRIEF COMMUNICATION

BRIEF COMMUNICATION

ENDOCRINOLOGY

NEUROLOGY

Clinical

SPECIAL CONTRIBUTION

Basic

MOLECULAR IMAGING

Basic

BRIEF COMMUNICATION

Challenging Case Studies

Letters to the Editor

SNMMI Newsline

In this issue

Issue highlights

Jump to